• Primary Antibody Dilution Buffer for PCNSL

  2026-08-12

  Learn how Primary Antibody Dilution Buffer can improve assay design for PCNSL research, from tissue penetration to background control. This guide translates single-cell metabolic findings into practical, appropriately cautious IHC, ICC, and ISH workflow decisions.

• GLP-1 (9-36) amide: Assay Workflow Guide

  2026-08-12

  Build cleaner GLP-1 receptor signaling research with a practical antagonist workflow designed around peptide handling, receptor-specific controls, and cAMP assay interpretation. The guide also separates evidence for GLP-1 (9-36) amide from findings generated with exendin(9-39), helping metabolic researchers avoid misleading potency or selectivity conclusions.

• Isoprenaline Hydrochloride Research Workflows

  2026-08-11

  Isoprenaline Hydrochloride, also known as isoproterenol, provides a controllable β1/β2-adrenergic challenge for cardiac, vascular, airway, and heart–brain experiments. This workflow-focused guide shows how to connect ECG, neural, endothelial, and functional readouts while avoiding common interpretation and formulation errors.

• Regorafenib Suppresses Melanoma via RRM2–ERK/E2F3

  2026-08-11

  A 2024 iScience study identifies RRM2 as a downstream mediator of Regorafenib activity in melanoma and connects its reduction to disrupted ERK/E2F3 signaling. The findings extend the mechanistic interpretation of BAY 73-4506 beyond broad kinase inhibition and provide a framework for studying melanoma growth, invasion, apoptosis, and tumor xenograft models.

• TG003 Cdc2-like Kinase Inhibitor for Splicing

  2026-08-10

  TG003 is a Cdc2-like kinase inhibitor that suppresses Clk-dependent phosphorylation of serine/arginine-rich splicing proteins. Its strongest reported biochemical activity is against Clk1 and Clk4, while ovarian-cancer evidence supports CLK2 as a mechanistic research target rather than proving TG003 efficacy in platinum-resistant tumors.

• IR-1061 for NIR-II In Vivo Imaging

  2026-08-09

  IR-1061 combines 1064 nm near-infrared fluorescence with a hydrophobic profile suited to carrier-based probe design. This guide translates its formulation behavior into practical workflows for deep-tissue, vascular, and other biomedical imaging assays while emphasizing aggregation control and solvent discipline.

• Aligned Ce6–Silk Fibers for Infected Wounds

  2026-08-08

  The reference study developed an aligned silk fibroin film containing conjugated Chlorin e6 (Ce6) nanofibers for light-activated treatment of S. aureus-infected wounds. Its central contribution is the integration of directional cell guidance, photodynamic antibacterial activity, mechanical compatibility, and later-stage macrophage polarization within one anisotropic scaffold.

• Valemetostat (DS-3201) in Immuno-Oncology Workflows

  2026-08-07

  Valemetostat (DS-3201) combines potent EZH2 pathway control with a practical platform for lymphoma, epigenetic cancer therapy, and adoptive T-cell assays. This guide translates its biochemical profile into dose-finding, tumor-priming, CAR-T co-culture, and troubleshooting workflows.

• HotStart Universal 2X Green qPCR Master Mix for Robust Gene

  2026-08-07

  Leverage the HotStart Universal 2X Green qPCR Master Mix for highly specific, reproducible quantification in real-time PCR gene expression workflows. Explore optimized protocol design, advanced troubleshooting, and unique features that set this hot-start Taq polymerase-based mix apart for immune transcriptomics and beyond.

• Recombinant Human Oncostatin M: Applied Cytokine Assays & Op

  2026-08-06

  APExBIO’s Recombinant Human Oncostatin M (E.coli, Tag Free, Lyophilized) enables robust, reproducible workflows for probing fibroblast and smooth muscle cell proliferation, cytokine signaling, and tumor modulation. This article delivers actionable protocol guidance, troubleshooting strategies, and highlights from breakthrough neuroinflammation research for translational and cell biology applications.

• RG7388 MDM2 Antagonist: Precision p53 Activation in Cancer M

  2026-08-06

  RG7388, a highly selective MDM2 antagonist supplied by APExBIO, enables robust p53 pathway activation and apoptosis induction in preclinical cancer models with wild-type p53. This article demystifies experimental workflows, highlights combinatorial therapy strategies, and provides evidence-based troubleshooting tips tailored to translational oncology research.

• NP-40 Lysis Buffer: Precision Extraction for Neuroimmune Sig

  2026-08-05

  Explore how NP-40 Lysis Buffer delivers non-denaturing, high-fidelity protein extraction for dissecting neuroimmune signaling pathways. This article uniquely bridges advanced lysis strategies with the latest insights into immune cell modulation.

• Gefitinib (ZD1839): Unraveling EGFR Signaling and Blue Light

  2026-08-05

  Explore how Gefitinib (ZD1839) enables precision inhibition of EGFR signaling, with a unique focus on its application in blue light-induced skin barrier research. This article offers advanced scientific and protocol insights for cancer and dermatological studies.

• Nigericin: Potassium/Hydrogen Ion Carrier in Oncology & Meta

  2026-08-04

  Nigericin’s unique role as a potassium/hydrogen ion carrier enables precise intracellular pH modulation, empowering both anticancer research and advanced mitochondrial assays. This article delivers stepwise protocols, troubleshooting insights, and evidence-based enhancements inspired by recent metabolic reprogramming studies.

• Peroxynitrite-Induced Necroptosis in Cardiac Microvascular I

  2026-08-04

  Liu et al. (2025) elucidate how hyperhomocysteinemia aggravates cardiac microvascular ischemia–reperfusion injury through peroxynitrite-driven ER stress and dysregulated calcium flux, culminating in necroptosis of endothelial cells. Their mechanistic insights identify IP3R-mediated calcium transfer as a tractable pathway and inform future design of necroptosis assays and therapeutic interventions.

7919 records 3/528 page Previous Next 12345 下5页 Last page